What are the first-line antibiotic treatments for common bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotic Treatments for Common Bacterial Infections

The first-line antibiotic treatment for common bacterial infections should be selected based on the suspected pathogen, with amoxicillin, ampicillin, or benzylpenicillin combined with gentamicin recommended for sepsis, high-dose amoxicillin or amoxicillin-clavulanate for respiratory infections, and fluoroquinolones reserved for specific indications. 1

Sepsis and Bloodstream Infections

First-line options:

  • Amoxicillin + gentamicin
  • Ampicillin + gentamicin
  • Benzylpenicillin + gentamicin

Second-line options:

  • Amikacin + cloxacillin
  • Cefotaxime
  • Ceftriaxone

The combination of a penicillin with an aminoglycoside provides coverage against both Gram-positive organisms (including Group B Streptococcus) and Gram-negative bacteria (Enterobacterales) 1.

Respiratory Tract Infections

Acute Bacterial Rhinosinusitis

  • First-line (mild disease, no recent antibiotics):

    • Adults: Amoxicillin (1.5-4 g/day) or amoxicillin-clavulanate (1.75-4 g/250 mg per day)
    • Children: High-dose amoxicillin (90 mg/kg/day) or amoxicillin-clavulanate (90 mg/6.4 mg per kg per day) 1
  • Alternative options: Cefpodoxime proxetil, cefuroxime axetil, or cefdinir

  • For β-lactam allergies: TMP/SMX, doxycycline, azithromycin, clarithromycin, or erythromycin (note: 20-25% bacteriologic failure rate possible) 1

Chronic Bronchitis Exacerbations

  • First-line (if at least 2 of 3 Anthonisen criteria present):

    • Amoxicillin
    • First-generation cephalosporins
    • Macrolides
    • Pristinamycin
    • Doxycycline 1
  • Second-line (treatment failure or frequent exacerbations):

    • Amoxicillin-clavulanate
    • Cefuroxime-axetil
    • Cefpodoxime-proxetil
    • Cefotiam-hexetil
    • Respiratory fluoroquinolones (levofloxacin, moxifloxacin) 1

Dental Infections

Dental Abscess

  • First-line: Amoxicillin 25-50 mg/kg/day divided into three doses 2
  • Second-line: Clindamycin 300-450 mg three times daily 2

Important Considerations for Specific Antibiotics

Fluoroquinolones (e.g., Levofloxacin)

  • Reserve for specific indications due to risk of serious adverse effects
  • Monitor for tendon rupture or swelling, especially in patients >60 years, those on corticosteroids, or with kidney/heart/lung transplants
  • Can worsen myasthenia gravis
  • Avoid in children under 18 when possible 3

Ceftriaxone

  • Monitor prothrombin time in patients with impaired vitamin K synthesis
  • Watch for gallbladder pseudolithiasis (especially in pediatric patients)
  • Ensure adequate hydration to prevent urolithiasis
  • Monitor for pancreatitis, especially in patients with risk factors for biliary stasis 4

Azithromycin

  • Use caution in patients with impaired hepatic function
  • Can exacerbate symptoms of myasthenia gravis
  • May potentiate effects of oral anticoagulants
  • Avoid aluminum and magnesium-containing antacids simultaneously 5

Antibiotic Selection Algorithm

  1. Identify infection site and likely pathogens
  2. Consider patient factors:
    • Age
    • Allergies
    • Comorbidities (renal/hepatic function)
    • Recent antibiotic exposure
    • Local resistance patterns
  3. Select appropriate first-line agent based on guidelines
  4. Reassess after 48-72 hours:
    • If improving: complete course
    • If not improving: switch to second-line therapy or reevaluate diagnosis

Common Pitfalls to Avoid

  • Overuse of broad-spectrum antibiotics when narrow-spectrum would suffice
  • Inadequate dosing leading to treatment failure and resistance
  • Failure to adjust therapy based on culture results when available
  • Inappropriate duration of therapy (too short or too long)
  • Neglecting local resistance patterns when selecting empiric therapy

Remember that penicillin, cloxacillin, and erythromycin should cover approximately 90% of Gram-positive infections 6, while more targeted therapy is needed for Gram-negative and anaerobic infections.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dental Abscess Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotics for gram-positive organisms.

British journal of hospital medicine, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.